The Healthcare Investor

Latest from The Healthcare Investor

Gauge Capital has announced it has invested in East Coast Institute for Research (ECIR).

ECIR, founded in 2007 and based in Jacksonville, Fla., is a clinical research site management organization focused primarily on the cardiovascular and metabolic therapeutic areas. The company has sites across northern Florida and Georgia.

Gauge, based in Southlake, Texas,

GTCR has announced it will acquire Cloudbreak Health from UpHealth for $180 million.

Cloudbreak, based in Columbus, Ohio, is a provider of healthcare-focused language interpretation services. Founded in 2003, the company’s core offering is Martti (My Accessible Real-Time Trusted Interpreter), a video remote interpretation solution designed to connect patients with interpreters in over 250

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their

On this episode of The Corner Series, McGuireWoods’ Geoff Cockrell invites Alessio Baraldi, managing director at Albaron Partners, to discuss value creation in healthcare provider services. Alessio provides insight into the equity structures that work best for his portfolios and how he approaches compensation to keep everyone aligned.“In an environment where there

The difficulties faced by healthcare provider consolidations could be temporary or they could indicate a long-term decline in the attractiveness of consolidation. Some challenges, like high debt and labor market imbalances, are temporary and don’t reflect the fundamental quality of the businesses involved.

On this episode of The Corner Series, McGuireWoods’ Geoff Cockrell is

The interview below is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. To recommend a leader for a future interview, email Holly Buckley at or Tim Fry at

Q: How do you ensure the platform’s organizational culture is appropriately conveyed to potential targets?

Rich Goode: The

The regulatory landscape for telehealth prescribing of controlled substances is evolving.

In episode 13 of Complications: Health Policy Unraveled, host Stephanie Kennan covers the DEA’s recent extension of pandemic-era telehealth prescribing flexibilities for controlled substances through 2024, marking the second extension. Originally set to expire in May, these extensions followed extensive public input, including 38,000